SIGNAPRED 4 Tablet is a pharmaceutical preparation containing Methylprednisolone 4 mg, a synthetic corticosteroid known for its potent anti-inflammatory and immunomodulatory properties. This medication is widely prescribed in both acute and chronic conditions where inflammation or immune system dysregulation plays a central role.
Methylprednisolone works by modulating the body’s immune response and reducing the production of inflammatory substances such as prostaglandins and leukotrienes. Its mechanism of action includes suppression of leukocyte migration and capillary permeability at the site of inflammation, effectively alleviating symptoms like swelling, redness, heat, and pain. It also helps reduce immune system hyperactivity in autoimmune disorders and allergies, thereby controlling disease progression.
SIGNAPRED 4 Tablet is particularly effective in managing conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), severe allergic reactions, asthma exacerbations, COPD flare-ups, skin disorders like eczema or psoriasis, and neurological conditions like multiple sclerosis. It is also used as part of cancer chemotherapy regimens, organ transplant protocols, and acute spinal cord injury management when prescribed under medical supervision.
Each tablet is formulated using premium-grade excipients and undergoes precision manufacturing at Bluepill Express’s WHO-GMP and ISO-certified facilities. Stringent quality control ensures batch-to-batch consistency, high bioavailability, and long shelf-life. Bluepill Express provides flexibility in packaging (such as blister or strip formats), private labeling, and documentation support for regulatory submissions including CTD dossiers, COA, and stability data for export purposes.
SIGNAPRED 4 Tablet is suitable for oral administration and can be prescribed alone or in combination with other medications based on clinical assessment. Due to its wide spectrum of use, it finds application in both hospital and retail settings across global markets. The product is well-suited for distribution in semi-regulated and non-regulated markets in Asia, Africa, South America, and the CIS region.
Being a corticosteroid, it should be prescribed and monitored by qualified medical professionals to avoid potential side effects associated with long-term or high-dose use, such as hyperglycemia, adrenal suppression, and bone demineralization. Bluepill Express ensures clear labeling and professional product inserts to support safe and appropriate use of the medication.
Description provided by bluepill express.
FIEO Registered
Export Ready
